CBD

Property	Information
Drug Name	CBD (Cannabidiol)
FDA Approval	Yes, for specific epilepsy syndromes; not FDA-approved for cancer treatment
Used for	Investigational use in cancer treatment, including symptom management and potential anti-tumor effects
Clinical Trial Phase	Preclinical studies and early human trials for cancer
Clinical Trial Explanation	Not specified
Common Side Effects	Tiredness, diarrhea, changes in appetite/weight; generally well-tolerated at doses used for epilepsy
OS without	Not specified
OS with	Not applicable; ongoing research into potential impacts on overall survival in cancer patients
PFS without	Not specified
PFS with	Not applicable; ongoing research into potential impacts on progression-free survival in cancer patients
Usefulness Rating	3
Usefulness Explanation	Not specified
Toxicity Level	Not specified
Toxicity Explanation	Not specified

Notes: CBD, a non-psychoactive component of cannabis, has been explored for its potential therapeutic effects in cancer treatment, including anti-inflammatory, analgesic, and anti-nausea properties, as well as possible direct anti-tumor effects. While preclinical studies have shown promising results, including inhibition of tumor growth and synergistic effects with chemotherapy in models of glioblastoma and other cancers, conclusive evidence from clinical trials is needed to fully understand its efficacy and optimal use in cancer treatment.

From Ben Williams Book: Not specified

Loading comments...